Skip to main content
SpringerLink
Log in

Antiinfektiosa: Antivirale Substanzen

  • Chapter
Pharmakotherapie bronchopulmonaler Erkrankungen

  • 93 Accesses

Zusammenfassung

Gemessen an der großen Zahl von Viren (ca. 200), die den Respirationstrakt infizieren können, sind nur wenige Erkrankungen therapierbar. Die Viren, die am häufigsten Erkrankungen der unteren Atemwege verursachen können, sind in Tabelle 1 aufgelistet [8, 10]. In der Regel werden nur schwere Infektionen durch humane Herpesviren (Zytomegalievirus, Varicella-Zoster-Virus und Herpes-simplex-Virus), Orthomyxoviren (Influenza) sowie Pa- ramyxoviren (RSV), häufig bei immunsupprimierten Patienten, therapiert. Präventiv stehen Schutzimpfungen gegen das Varicella-Zoster-Virus, das Masernvirus und die Influenza A/B-Viren zur Verfügung.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. . Alrabiah FA, Sacks SL (1996) New antiher- pesvirus agents. Drugs 52: 17 – 32

    Article  PubMed  CAS  Google Scholar 

  2. . Beutner KR, Friedman DJ, Forszpaniak C, Andersen PL, Wood M (1995) Valaciclovir compared with aciclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother 39: 1546 – 1553

    PubMed  CAS  Google Scholar 

  3. . Chrisp P, Clissold SP (1991) Foscarnet, a review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirusretinitis. Drugs 41: 104 – 129

    Article  PubMed  CAS  Google Scholar 

  4. . De Clercq E (1993) Antivirals for the treatment of herpesvirus infections. J Antimicrob Chemother 32: 121 – 132

    PubMed  Google Scholar 

  5. . Degreef H, Famciclovir herpes zoster clinical study group (1994) Famciclovir, a new oral antiherpes drug: results of the first controlled clinical study demonstrating its efficancy and safty in the treatment of uncomplicated herpes zoster in immunocompetent patients. Antimicrob Agents 4: 241 – 246

    Article  Google Scholar 

  6. . Dolin R (1985) Antiviral chemotherapy and chemoprophylaxis. Science 227: 1296 – 1303

    Article  PubMed  CAS  Google Scholar 

  7. . Faulds D, Heel RC (1990) Ganciclovir, a review of its antiviral activity, pharmacokinetic properties and therapeutic efficancy in cytomegalovirus infections. Drugs 39: 597 – 638

    Article  PubMed  CAS  Google Scholar 

  8. . Galasso J, Whitley RJ, Merigan TC (ed) (1990) Antiviral agents and viral diseases of man. Raven Press, New York

    Google Scholar 

  9. . Jeffries DJ, De Clercq E (ed) (1995) Antiviral chemotherapy. Wiley, West Sussex

    Google Scholar 

  10. . Mandell GL, Bennett JE, Dolin R (ed) (1995) Principles and practice of infectious diseases. Wiley, New York

    Google Scholar 

  11. . Markham A, Faulds D (1994) Ganciclovir, an update of its therapeutic use in cytomegalovirus infections. Drugs 48: 455 – 484

    Article  PubMed  CAS  Google Scholar 

  12. . Morse GD, Shelton M, O’Donnel AM (1993) Comparative pharmakokinetics of antiviral nucleoside analogues. Clin Pharmacokinet 24: 101 – 123

    Article  PubMed  CAS  Google Scholar 

  13. O’Brien JJ, Campoli-Richards DM (1989) Aciclovir, an updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficancy. Drugs 37: 233 – 309

    Article  PubMed  Google Scholar 

  14. . Reißer C, Baehr M (1994) Aciclovir: Indika- tionen, Eigenschaften und Verarbeitung in der Eigenproduktion. Krankenhauspharma- zie 15: 1 – 8

    Google Scholar 

  15. . Vere Hodge RA (1993) Famciclovir and penciclovir. The mode of action of famciclovir including its conversion to penciclovir. Antiviral Chem Chemother 4: 67 – 84

    CAS  Google Scholar 

  16. Wellcome Foundation (1994) Valaciclovir, product monograph

    Google Scholar 

  17. . Weller S, Blum R, Doucett M, Burnette T, Cederberg D, de Miranda P, Smiley L (1993) Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers. Clin Pharmacol Therap 54: 5595 – 605

    Article  Google Scholar 

  18. . Wutzler P, DeClercq E., Wutke K, Färber I (1995) Oral brivudin vs. intravenous aciclovir in the treatment of herpes zoster in immunocompromised patients: a randomized double-blind trail. J Med Virol 46: 252 – 257

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. D. Michel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Mertens
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Wilhelminenspital der Stadt Wien, Wien, Österreich

    Friedrich Kummer

  2. Ruhrlandklinik, Essen, Deutschland

    Nikolaus Konietzko

  3. Universitätsspital, Zürich, Schweiz

    Tullio C. Medici

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag/Wien

About this chapter

Cite this chapter

Michel, D., Mertens, T. (2000). Antiinfektiosa: Antivirale Substanzen. In: Kummer, F., Konietzko, N., Medici, T.C. (eds) Pharmakotherapie bronchopulmonaler Erkrankungen. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6761-8_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-6761-8_14

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-7404-3

  • Online ISBN: 978-3-7091-6761-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation